Evolution of the Average Target: AstraZeneca PLC

Evolution of the Average Target - AstraZeneca PLC

Evolution of the Target Price: AstraZeneca PLC

Evolution of the Target Price - AstraZeneca PLC

Changes in Analyst Recommendations: AstraZeneca PLC

fe7f1d085680910cc880e99.dh3CYn4uIZQ-4qwO6hV6TcRI-QZ-5LcPz8tz87JemMI.JHr0Mgdba-dsgNVe3GVCF4cDsUcEsdZBiLMKioBr65AFULQoKwMS3F_U3w~777968166f58cbc0668053a22197cc0a
30/10 AstraZeneca: Q3 reassures investors, but valuation lacks a safety net Alphavalue
30/10 AstraZeneca Kept at Buy as BofA Notes Q3 Results, 'Very Busy' Pipeline MT
30/10 AstraZeneca PLC : UBS reiterates its Buy rating ZD
30/10 AstraZeneca PLC : Buy rating from Jefferies ZD
30/10 AstraZeneca PLC : Receives a Buy rating from Bernstein ZD
28/10 AstraZeneca PLC : Deutsche Bank remains Neutral ZD
27/10 AstraZeneca PLC : Receives a Buy rating from Jefferies ZD
27/10 AstraZeneca PLC : JP Morgan reaffirms its Buy rating ZD
27/10 AstraZeneca PLC : RBC maintains a Buy rating ZD
26/10 AstraZeneca PLC : JP Morgan reaffirms its Buy rating ZD
21/10 AstraZeneca PLC : Gets a Buy rating from JP Morgan ZD
20/10 AstraZeneca PLC : Jefferies keeps its Buy rating ZD
16/10 AstraZeneca PLC : Berenberg remains its Buy rating ZD
15/10 RBC Reaffirms AstraZeneca's Outperform Rating Ahead of Q3 Results MT
15/10 AstraZeneca PLC : UBS gives a Buy rating ZD
15/10 AstraZeneca PLC : Gets a Buy rating from RBC ZD
14/10 AstraZeneca PLC : Deutsche Bank reiterates its Neutral rating ZD
07/10 Berenberg Trims AstraZeneca PT, Affirms Outperform Rating MT
07/10 Deutsche Bank ups Glencore, BHP price targets AN
07/10 AstraZeneca PLC : Buy rating from Berenberg ZD
07/10 AstraZeneca PLC : Jefferies gives a Buy rating ZD
07/10 AstraZeneca PLC : Bernstein reaffirms its Buy rating ZD
06/10 Genmab in Good Health, Schneider Lacks Energy Zonebourse
06/10 BofA Forecasts 'In-line' Q3, Unchanged FY26 Outlook for AstraZeneca Amid Oncology Momentum MT
30/09 AstraZeneca PLC : Deutsche Bank reaffirms its Neutral rating ZD

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
-1.45%
+2.27%
-3.97%
-2.72%
+7%
-5.37%
+12.5%
-14.74%
-3.15%
Average -1.07%
Weighted average by Cap. -0.77%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
187.02USD
Average target price
210.53USD
Spread / Average Target
+12.57%
High Price Target
265.26USD
Spread / Highest target
+41.83%
Low Price Target
154.83USD
Spread / Lowest Target
-17.21%

Analyst Consensus Detail

Analyst consensus - AstraZeneca PLC

Consensus revision (last 18 months)

Consensus revision (last 18 months) - AstraZeneca PLC
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - AstraZeneca PLC